MK-2420 SAD Study
MK-2420-001
Phase 1 other active
Quick answer
MK-2420 SAD Study for Rheumatoid arthritis is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Rheumatoid arthritis
- Phase
- Phase 1
- Modality
- other
- Status
- active